| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.38 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.31 | 5e-08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-19 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 6e-09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-11 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-10 |